Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review.
David S LakomyJuliana WuDorothy LombeEmmanouil PapasavvasSusan Citonje MsadabweYimin GengLuis J MontanerElizabeth ChiaoLilie L LinPublished in: Cancer medicine (2021)
The immunologic interplay at work in cervical cancer development, progression, and treatment is complex. Strong evidence was found in favor of lymphopenia and elevated neutrophil-to-lymphocyte ratio being prognostic for worse outcomes with other markers showing potential associations as well. Although the interpretation of immune status with regard to treatment approach remains unclear, future studies should aim to tailor treatment that minimizes possible detrimental immune effects.